This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignee: Bruker Cellular Analysis, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ke-Chih Lin: Innovator in Cellular Therapeutics
Introduction
Ke-Chih Lin is a prominent inventor based in Emeryville, CA (US). He has made significant contributions to the field of cellular therapeutics, particularly through his innovative patent work. His expertise and dedication to advancing medical technology have positioned him as a key figure in his industry.
Latest Patents
Ke-Chih Lin holds a patent for "Systems and apparatuses for cellular therapeutics manufacture." This patent describes a cartridge designed for manufacturing a population of cells suitable for formulation as a cellular therapeutic. The technology disclosed includes systems for operating the cartridges and methods to generate populations of cells, such as T-cells, including CAR T-cells. Notably, the systems and methods can be largely automated, enhancing efficiency in therapeutic applications. He has 1 patent to his name.
Career Highlights
Ke-Chih Lin is currently employed at Bruker Cellular Analysis, Inc., where he continues to develop innovative solutions in cellular analysis and therapeutics. His work is instrumental in pushing the boundaries of what is possible in the field of medicine.
Collaborations
Throughout his career, Ke-Chih Lin has collaborated with notable colleagues, including Darcy K Kelly-Greene and Peter J Beemiller. These collaborations have fostered an environment of innovation and have contributed to the advancement of cellular therapeutics.
Conclusion
Ke-Chih Lin's contributions to the field of cellular therapeutics through his patent and work at Bruker Cellular Analysis, Inc. highlight his role as an influential inventor. His dedication to innovation continues to impact the medical field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile